筛查试验的使用、诊断等待时间和乳腺癌与前列腺癌的等待相关满意度。

Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer.

机构信息

Division of Community Health and Humanities, Memorial University, St. John's, NL.

出版信息

Curr Oncol. 2014 Jun;21(3):e441-8. doi: 10.3747/co.21.1843.

DOI:10.3747/co.21.1843

PMID:24940104

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4059808/

Abstract

BACKGROUND

Understanding factors relating to the perception of wait time by patients is key to improving the patient experience.

METHODS

We surveyed 122 breast and 90 prostate cancer patients presenting at clinics or listed on the cancer registry in Newfoundland and Labrador and reviewed their charts. We compared the wait time (first visit to diagnosis) and the wait-related satisfaction for breast and prostate cancer patients who received regular screening tests and whose cancer was screening test-detected ("screen/screen"); who received regular screening tests and whose cancer was symptomatic ("screen/symptomatic"); who did not receive regular screening tests and whose cancer was screen test-detected ("no screen/screen"); and who did not receive regular screening tests and whose cancer was symptomatic ("no screen/symptomatic").

RESULTS

Although there were no group differences with respect to having a long wait (greater than the median of 47.5 days) for breast cancer patients (47.8% screen/screen, 54.7% screen/symptomatic, 50.0% no screen/ screen, 40.0% no screen/symptomatic; p = 0.814), a smaller proportion of the screen/symptomatic patients were satisfied with their wait (72.5% screen/ screen, 56.4% screen/symptomatic, 100% no screen/ screen, 90.9% no screen/symptomatic; p = 0.048). A larger proportion of screen/symptomatic prostate cancer patients had long waits (>104.5 days: 41.3% screen/screen, 92.0% screen/symptomatic, 46.0% no screen/screen, 40.0% no screen/symptomatic; p = 0.011) and a smaller proportion of screen/ symptomatic patients were satisfied with their wait (71.2% screen/screen, 30.8% screen/symptomatic, 76.9% no screen/screen, 90.9% no screen/symptomatic; p = 0.008).

CONCLUSIONS

Diagnosis-related wait times and satisfaction were poorest among patients who received regular screening tests but whose cancer was not detected by those tests.

摘要

背景

了解与患者对等待时间的感知相关的因素对于改善患者体验至关重要。

方法

我们调查了在纽芬兰和拉布拉多的诊所就诊或列在癌症登记册上的 122 名乳腺癌和 90 名前列腺癌患者，并查阅了他们的病历。我们比较了接受常规筛查且癌症是筛查检测发现的（“筛查/筛查”）、接受常规筛查且癌症是症状性的（“筛查/症状性”）、未接受常规筛查且癌症是筛查检测发现的（“无筛查/筛查”）以及未接受常规筛查且癌症是症状性的（“无筛查/症状性”）的乳腺癌和前列腺癌患者的等待时间（首次就诊至诊断）和与等待相关的满意度。

结果

尽管对于乳腺癌患者来说，等待时间较长（超过中位数 47.5 天）的比例没有组间差异（筛查/筛查 47.8%，筛查/症状性 54.7%，无筛查/筛查 50.0%，无筛查/症状性 40.0%；p = 0.814），但症状性筛查患者对等待时间的满意度较低（筛查/筛查 72.5%，筛查/症状性 56.4%，无筛查/筛查 100%，无筛查/症状性 90.9%；p = 0.048）。较大比例的症状性前列腺癌患者等待时间较长（>104.5 天：筛查/筛查 41.3%，筛查/症状性 92.0%，无筛查/筛查 46.0%，无筛查/症状性 40.0%；p = 0.011），且对等待时间感到满意的症状性筛查患者比例较低（筛查/筛查 71.2%，筛查/症状性 30.8%，无筛查/筛查 76.9%，无筛查/症状性 90.9%；p = 0.008）。